These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9176278)

  • 1. Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats.
    Regan CP; Anderson PG; Bishop SP; Berecek KH
    Am J Physiol; 1997 May; 272(5 Pt 2):H2131-8. PubMed ID: 9176278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril prevents vascular and fibrotic changes but not cardiac hypertrophy in aortic-banded rats.
    Regan CP; Anderson PG; Bishop SP; Berecek KH
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H906-13. PubMed ID: 8853324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R; Young SD; Strosberg AM
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB; Black MJ; Bertram JF; Bobik A
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
    Ishiye M; Umemura K; Uematsu T; Nakashima M
    Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
    Linz W; Henning R; Schölkens BA
    J Hypertens Suppl; 1991 Dec; 9(6):S400-1. PubMed ID: 1840203
    [No Abstract]   [Full Text] [Related]  

  • 8. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice.
    Rockman HA; Wachhorst SP; Mao L; Ross J
    Am J Physiol; 1994 Jun; 266(6 Pt 2):H2468-75. PubMed ID: 8024008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor.
    Dostal DE; Baker KM
    Am J Hypertens; 1992 May; 5(5 Pt 1):276-80. PubMed ID: 1533768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts.
    Lopez JJ; Lorell BH; Ingelfinger JR; Weinberg EO; Schunkert H; Diamant D; Tang SS
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H844-52. PubMed ID: 8067441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S; Iwao H
    J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
    Jones ES; Black MJ; Widdop RE
    J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1996 Sep; 28(3):397-402. PubMed ID: 8794823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats.
    Ruzicka M; Yuan B; Leenen FH
    Circulation; 1994 Jul; 90(1):484-91. PubMed ID: 8026035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac and vascular hypertrophy in hypertension due to angiotensin II. Effect of losartan and bosentan].
    Herizi A; Belabbas H; Mimran A; Jover B
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):983-6. PubMed ID: 10989742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries.
    Thorup C; Kornfeld M; Winaver JM; Goligorsky MS; Moore LC
    Pflugers Arch; 1998 Feb; 435(3):432-4. PubMed ID: 9426302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats.
    Baba HA; Iwai T; Bauer M; Irlbeck M; Schmid KW; Zimmer HG
    J Mol Cell Cardiol; 1999 Feb; 31(2):445-55. PubMed ID: 10093056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.
    Everett AD; Tufro-McReddie A; Fisher A; Gomez RA
    Hypertension; 1994 May; 23(5):587-92. PubMed ID: 8175166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.
    Qiu C; Engels K; Baylis C
    Am J Physiol; 1994 May; 266(5 Pt 2):R1470-6. PubMed ID: 8203622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.